{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:47:50Z","timestamp":1793296070068,"version":"4.5.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["32072837"],"award-info":[{"award-number":["32072837"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virus Genes"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11262-026-02243-w","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:37:34Z","timestamp":1779298654000},"page":"561-575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Roles of the M2 protein of influenza A virus"],"prefix":"10.1007","volume":"62","author":[{"given":"Weigang","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"1","key":"2243_CR1","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s42003-021-02388-4","volume":"4","author":"M Nakano","year":"2021","unstructured":"Nakano M, Sugita Y, Kodera N, Miyamoto S, Muramoto Y, Wolf M et al (2021) Ultrastructure of influenza virus ribonucleoprotein complexes during viral RNA synthesis. Commun Biol 4(1):858","journal-title":"Commun Biol"},{"issue":"9","key":"2243_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/v10090497","volume":"10","author":"A Mostafa","year":"2018","unstructured":"Mostafa A, Abdelwhab E, Mettenleiter T, Pleschka S (2018) Zoonotic potential of influenza A viruses: a comprehensive overview. Viruses 10(9):497","journal-title":"Viruses"},{"issue":"3","key":"2243_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.18388\/abp.2014_1857","volume":"61","author":"B Szewczyk","year":"2014","unstructured":"Szewczyk B, Bie\u0144kowska-Szewczyk K, Kr\u00f3l E (2014) Introduction to molecular biology of influenza A viruses. Acta Biochim Pol 61(3):397\u2013401","journal-title":"Acta Biochim Pol"},{"issue":"11","key":"2243_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002998","volume":"8","author":"A Pekosz","year":"2012","unstructured":"Pekosz A, Wise HM, Hutchinson EC, Jagger BW, Stuart AD, Kang ZH et al (2012) Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog 8(11):e1002998","journal-title":"PLoS Pathog"},{"issue":"10","key":"2243_CR5","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3390\/pathogens9100812","volume":"9","author":"W Hao","year":"2020","unstructured":"Hao W, Wang L, Li S (2020) Roles of the non-structural proteins of influenza A virus. Pathogens 9(10):812","journal-title":"Pathogens"},{"issue":"10","key":"2243_CR6","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.3390\/v5102424","volume":"5","author":"E Hutchinson","year":"2013","unstructured":"Hutchinson E, Fodor E (2013) Transport of the influenza virus genome from nucleus to nucleus. Viruses 5(10):2424\u20132446","journal-title":"Viruses"},{"issue":"1\u20132","key":"2243_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.virusres.2006.09.013","volume":"124","author":"S Boulo","year":"2007","unstructured":"Boulo S, Akarsu H, Ruigrok RWH, Baudin F (2007) Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes. Virus Res 124(1\u20132):12\u201321","journal-title":"Virus Res"},{"key":"2243_CR8","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1073\/pnas.78.7.4170","volume":"78","author":"RA Lamb","year":"1981","unstructured":"Lamb RA, Lai CJ, Choppin PW (1981) Sequences of mRNAs derived from genome RNA segment 7 of influenza virus colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A 78:4170\u20134174","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2243_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0092-8674(85)90211-9","volume":"40","author":"RA Lamb","year":"1985","unstructured":"Lamb RA, Zebedee SL, Richardson CD (1985) Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell 40(3):627\u2013633","journal-title":"Cell"},{"issue":"2","key":"2243_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.bbamem.2017.10.026","volume":"1860","author":"C Ma","year":"2018","unstructured":"Ma C, Wang J (2018) Functional studies reveal the similarities and differences between AM2 and BM2 proton channels from influenza viruses. Biochim Biophys Acta Biomembr 1860(2):272\u2013280","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"1","key":"2243_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1534-5807(03)00190-4","volume":"5","author":"JA Mould","year":"2003","unstructured":"Mould JA, Paterson RG, Takeda M, Ohigashi Y, Venkataraman P, Lamb RA et al (2003) Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes. Dev Cell 5(1):175\u2013184","journal-title":"Dev Cell"},{"issue":"10","key":"2243_CR12","doi-asserted-by":"publisher","first-page":"e1003657","DOI":"10.1371\/journal.ppat.1003657","volume":"9","author":"K Subbarao","year":"2013","unstructured":"Subbarao K, Tong S, Zhu X, Li Y, Shi M, Zhang J et al (2013) New world bats harbor diverse influenza A viruses. PLoS Pathog 9(10):e1003657","journal-title":"PLoS Pathog"},{"issue":"11","key":"2243_CR13","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1073\/pnas.1116200109","volume":"109","author":"S Tong","year":"2012","unstructured":"Tong S, Li Y, Rivailler P, Conrardy C, Castillo DAA, Chen L-M et al (2012) A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci 109(11):4269\u20134274","journal-title":"Proc Natl Acad Sci"},{"issue":"7746","key":"2243_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-019-0955-3","volume":"567","author":"U Karakus","year":"2019","unstructured":"Karakus U, Thamamongood T, Ciminski K, Ran W, G\u00fcnther SC, Pohl MO et al (2019) MHC class II proteins mediate cross-species entry of bat influenza viruses. Nature 567(7746):109\u2013112","journal-title":"Nature"},{"issue":"10","key":"2243_CR15","doi-asserted-by":"publisher","first-page":"e1004420","DOI":"10.1371\/journal.ppat.1004420","volume":"10","author":"V Thiel","year":"2014","unstructured":"Thiel V, Zhou B, Ma J, Liu Q, Bawa B, Wang W et al (2014) Characterization of uncultivable bat influenza virus using a replicative synthetic virus. PLoS Pathog 10(10):e1004420","journal-title":"PLoS Pathog"},{"issue":"4","key":"2243_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1099\/jgv.0.000715","volume":"98","author":"J Yang","year":"2017","unstructured":"Yang J, Lee J, Ma J, Lang Y, Nietfeld J, Li Y et al (2017) Pathogenicity of modified bat influenza virus with different M genes and its reassortment potential with swine influenza A virus. J Gen Virol 98(4):577\u2013584","journal-title":"J Gen Virol"},{"key":"2243_CR17","doi-asserted-by":"publisher","first-page":"e0038823","DOI":"10.1128\/jvi.00388-23","volume":"97","author":"D Thompson","year":"2023","unstructured":"Thompson D, Cismaru CV, Rougier JS, Schwemmle M, Zimmer G (2023) The M2 proteins of bat influenza A viruses reveal atypical features compared to conventional M2 proteins. J Virol 97:e0038823","journal-title":"J Virol"},{"key":"2243_CR18","doi-asserted-by":"publisher","first-page":"e0086424","DOI":"10.1128\/jvi.00864-24","volume":"98","author":"LSL Wang","year":"2024","unstructured":"Wang LSL, Liu H, Zhang J, Yang W, Schountz T, Ma W (2024) Incompatible packaging signals and impaired protein functions hinder reassortment of bat H17N10 or H18N11 segment 7 with human H1N1 influenza A viruses. J Virol 98:e0086424","journal-title":"J Virol"},{"issue":"1","key":"2243_CR19","doi-asserted-by":"publisher","first-page":"18928","DOI":"10.1038\/s41598-023-45945-z","volume":"13","author":"X Meng","year":"2023","unstructured":"Meng X, Templeton C, Clementi C, Veit M (2023) The role of an amphiphilic helix and transmembrane region in the efficient acylation of the M2 protein from influenza virus. Sci Rep 13(1):18928","journal-title":"Sci Rep"},{"issue":"6","key":"2243_CR20","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.cell.2010.08.029","volume":"142","author":"JS Rossman","year":"2010","unstructured":"Rossman JS, Jing X, Leser GP, Lamb RA (2010) Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell 142(6):902\u2013913","journal-title":"Cell"},{"issue":"38","key":"2243_CR21","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1021\/acs.biochem.6b00727","volume":"55","author":"B Kwon","year":"2016","unstructured":"Kwon B, Hong M (2016) The influenza M2 ectodomain regulates the conformational equilibria of the transmembrane proton channel: insights from solid-state nuclear magnetic resonance. Biochemistry 55(38):5387\u20135397","journal-title":"Biochemistry"},{"issue":"10","key":"2243_CR22","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1128\/jvi.65.10.5491-5498.1991","volume":"65","author":"OTG Toshihiro Ito","year":"1991","unstructured":"Toshihiro Ito OTG (1991) Yoshihiro Kawaoka, William J Bean, Robert G Webster Evolution of the M gene of the influenza A virus in different host species large-scale sequence analysis. J Virol 65(10):5491\u20135498","journal-title":"J Virol"},{"issue":"45","key":"2243_CR23","doi-asserted-by":"publisher","first-page":"6280","DOI":"10.1016\/j.vaccine.2009.07.007","volume":"27","author":"W Fiers","year":"2009","unstructured":"Fiers W, De Filette M, Bakkouri KE, Schepens B, Roose K, Schotsaert M et al (2009) M2e-based universal influenza A vaccine. Vaccine 27(45):6280\u20136283","journal-title":"Vaccine"},{"issue":"12","key":"2243_CR24","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1529\/biophysj.106.090183","volume":"92","author":"J Hu","year":"2007","unstructured":"Hu J, Asbury T, Achuthan S, Li C, Bertram R, Quine JR et al (2007) Backbone structure of the amantadine-blocked trans-membrane domain M2 proton channel from influenza A virus. Biophys J 92(12):4335\u20134343","journal-title":"Biophys J"},{"issue":"11","key":"2243_CR25","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/pro.2158","volume":"21","author":"M Hong","year":"2012","unstructured":"Hong M, DeGrado WF (2012) Structural basis for proton conduction and inhibition by the influenza M2 protein. Protein Sci 21(11):1620\u20131633","journal-title":"Protein Sci"},{"issue":"8","key":"2243_CR26","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1021\/ja2081185","volume":"134","author":"F Hu","year":"2011","unstructured":"Hu F, Schmidt-Rohr K, Hong M (2011) NMR detection of pH-dependent histidine-water proton exchange reveals the conduction mechanism of a transmembrane proton channel. J Am Chem Soc 134(8):3703\u20133713","journal-title":"J Am Chem Soc"},{"issue":"42","key":"2243_CR27","doi-asserted-by":"publisher","first-page":"39880","DOI":"10.1074\/jbc.M206582200","volume":"277","author":"Y Tang","year":"2002","unstructured":"Tang Y, Zaitseva F, Lamb RA, Pinto LH (2002) The gate of the influenza virus M2 proton channel is formed by a single tryptophan residue. J Biol Chem 277(42):39880\u201339886","journal-title":"J Biol Chem"},{"issue":"20","key":"2243_CR28","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1021\/bi0028441","volume":"40","author":"ATM Okada","year":"2001","unstructured":"Okada ATM, Takeuchi H (2001) Protonation of histidine and histidine-tryptophan interaction in the activation of the M2 ion channel from influenza A virus. Biochemistry 40(20):6053\u20136060","journal-title":"Biochemistry"},{"key":"2243_CR29","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1021\/bi0028441","volume":"40","author":"A Okada","year":"2001","unstructured":"Okada A, Miura T, Takeuchi H (2001) Protonation of histidine and histidine-tryptophan interaction in the activation of the M2 ion channel from influenza a virus. Biochemistry 40:6053\u20136060","journal-title":"Biochemistry"},{"issue":"22","key":"2243_CR30","doi-asserted-by":"publisher","first-page":"21463","DOI":"10.1074\/jbc.M412406200","volume":"280","author":"P Venkataraman","year":"2005","unstructured":"Venkataraman P, Lamb RA, Pinto LH (2005) Chemical rescue of histidine selectivity filter mutants of the M2 ion channel of influenza A virus. J Biol Chem 280(22):21463\u201321472","journal-title":"J Biol Chem"},{"issue":"12","key":"2243_CR31","doi-asserted-by":"publisher","first-page":"8391","DOI":"10.1128\/jvi.70.12.8391-8401.1996","volume":"70","author":"MGW Bui","year":"1996","unstructured":"Bui MGW, Helenius A (1996) Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J Virol 70(12):8391\u20138401","journal-title":"J Virol"},{"issue":"4","key":"2243_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0092-8674(92)90219-3","volume":"69","author":"A Helenius","year":"1992","unstructured":"Helenius A (1992) Unpacking the incoming influenza virus. Cell 69(4):577\u2013578","journal-title":"Cell"},{"key":"2243_CR33","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1128\/jvi.68.3.1551-1563.1994","volume":"68","author":"LJ Holsinger","year":"1994","unstructured":"Holsinger LJ, Nichani D, Pinto LH, Lamb RA (1994) Influenza A virus M2 ion channel protein a structure-function analysis. J Virol 68:1551\u20131563","journal-title":"J Virol"},{"issue":"35","key":"2243_CR34","doi-asserted-by":"publisher","first-page":"15409","DOI":"10.1073\/pnas.1009997107","volume":"107","author":"T Leiding","year":"2010","unstructured":"Leiding T, Wang J, Martinsson J, DeGrado WF, \u00c5rsk\u00f6ld SP (2010) Proton and cation transport activity of the M2 proton channel from influenza A virus. Proc Natl Acad Sci U S A 107(35):15409\u201315414","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2243_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1113\/jphysiol.1996.sp021495","volume":"494","author":"IVFMG Chizhmakov","year":"1996","unstructured":"Chizhmakov IVFMG, Ogden DC, Hayhurst A, Antoniou M, Hay AJ (1996) Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells. J Physiol 494(2):329\u2013336","journal-title":"J Physiol"},{"issue":"7","key":"2243_CR36","doi-asserted-by":"publisher","first-page":"184373","DOI":"10.1016\/j.bbamem.2024.184373","volume":"1866","author":"YI Gamage","year":"2024","unstructured":"Gamage YI, Wadumesthri Y, Guti\u00e9rrez HR, Voronine DV, Pan J (2024) The impact of transmembrane peptides on lipid bilayer structure and mechanics: a study of the transmembrane domain of the influenza A virus M2 protein. Biochim Biophys Acta Biomembr 1866(7):184373","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"11","key":"2243_CR37","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1110\/ps.03168503","volume":"12","author":"C Tian","year":"2009","unstructured":"Tian C, Gao PF, Pinto LH, Lamb RA, Cross TA (2009) Initial structural and dynamic characterization of the M2 protein transmembrane and amphipathic helices in lipid bilayers. Protein Sci 12(11):2597\u20132605","journal-title":"Protein Sci"},{"issue":"7178","key":"2243_CR38","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature06531","volume":"451","author":"JR Schnell","year":"2008","unstructured":"Schnell JR, Chou JJ (2008) Structure and mechanism of the M2 proton channel of influenza A virus. Nature 451(7178):591\u2013595","journal-title":"Nature"},{"issue":"2","key":"2243_CR39","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.abb.2009.02.001","volume":"486","author":"P Zou","year":"2009","unstructured":"Zou P, Wu F, Lu L, Huang J-H, Chen Y-H (2009) The cytoplasmic domain of influenza M2 protein interacts with caveolin-1. Arch Biochem Biophys 486(2):150\u2013154","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"2243_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1042\/BJ20110706","volume":"437","author":"B Thaa","year":"2011","unstructured":"Thaa B, Levental I, Herrmann A, Veit M (2011) Intrinsic membrane association of the cytoplasmic tail of influenza virus M2 protein and lateral membrane sorting regulated by cholesterol binding and palmitoylation. Biochem J 437(3):389\u2013397","journal-title":"Biochem J"},{"issue":"20","key":"2243_CR41","doi-asserted-by":"publisher","first-page":"10059","DOI":"10.1128\/JVI.01184-08","volume":"82","author":"BJ Chen","year":"2008","unstructured":"Chen BJ, Leser GP, Jackson D, Lamb RA (2008) The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding. J Virol 82(20):10059\u201310070","journal-title":"J Virol"},{"issue":"2","key":"2243_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.chom.2014.01.006","volume":"15","author":"R Beale","year":"2014","unstructured":"Beale R, Wise H, Stuart A, Ravenhill BJ, Digard P, Randow F (2014) A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability. Cell Host Microbe 15(2):239\u2013247","journal-title":"Cell Host Microbe"},{"issue":"10","key":"2243_CR43","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1128\/JVI.00119-10","volume":"84","author":"JS Rossman","year":"2010","unstructured":"Rossman JS, Jing X, Leser GP, Balannik V, Pinto LH, Lamb RA (2010) Influenza virus M2 ion channel protein is necessary for filamentous virion formation. J Virol 84(10):5078\u20135088","journal-title":"J Virol"},{"issue":"18","key":"2243_CR44","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1021\/jacs.5b02510","volume":"137","author":"SY Liao","year":"2015","unstructured":"Liao SY, Yang Y, Tietze D, Hong M (2015) The influenza M2 cytoplasmic tail changes the proton-exchange equilibria and the backbone conformation of the transmembrane histidine residue to facilitate proton conduction. J Am Chem Soc 137(18):6067\u20136077","journal-title":"J Am Chem Soc"},{"issue":"1","key":"2243_CR45","doi-asserted-by":"publisher","first-page":"44695","DOI":"10.1038\/srep44695","volume":"7","author":"A Martyna","year":"2017","unstructured":"Martyna A, Bahsoun B, Badham MD, Srinivasan S, Howard MJ, Rossman JS (2017) Membrane remodeling by the M2 amphipathic helix drives influenza virus membrane scission. Sci Rep 7(1):44695","journal-title":"Sci Rep"},{"issue":"3","key":"2243_CR46","doi-asserted-by":"publisher","first-page":"e01605","DOI":"10.1128\/JVI.01605-19","volume":"94","author":"B Hu","year":"2020","unstructured":"Hu B, Siche S, M\u00f6ller L, Veit M (2020) Amphipathic helices of cellular proteins can replace the helix in M2 of influenza A virus with only small effects on virus replication. J Virol 94(3):e01605-e1619","journal-title":"J Virol"},{"issue":"2","key":"2243_CR47","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1099\/vir.0.038554-0","volume":"93","author":"B Thaa","year":"2012","unstructured":"Thaa B, Tielesch C, M\u00f6ller L, Schmitt AO, Wolff T, Bannert N et al (2012) Growth of influenza A virus is not impeded by simultaneous removal of the cholesterol-binding and acylation sites in the M2 protein. J Gen Virol 93(2):282\u2013292","journal-title":"J Gen Virol"},{"issue":"2","key":"2243_CR48","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.virol.2010.06.035","volume":"405","author":"SM Stewart","year":"2010","unstructured":"Stewart SM, Wu W-H, Lalime EN, Pekosz A (2010) The cholesterol recognition\/interaction amino acid consensus motif of the influenza A virus M2 protein is not required for virus replication but contributes to virulence. Virology 405(2):530\u2013538","journal-title":"Virology"},{"issue":"24","key":"2243_CR49","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1016\/j.bpj.2021.11.023","volume":"120","author":"A Petrich","year":"2021","unstructured":"Petrich A, Dunsing V, Bobone S, Chiantia S (2021) Influenza A M2 recruits M1 to the plasma membrane: a fluorescence fluctuation microscopy study. Biophys J 120(24):5478\u20135490","journal-title":"Biophys J"},{"key":"2243_CR50","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1743-422X-7-108","volume":"7","author":"L Sun","year":"2010","unstructured":"Sun L, Hemg\u00e5rd GV, Susanto SA, Wirth M (2010) Caveolin-1 influences human influenza A virus (H1N1) multiplication in cell culture. Virol J 7:108","journal-title":"Virol J"},{"key":"2243_CR51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.virol.2014.05.028","volume":"462\u2013463","author":"K Bohm","year":"2014","unstructured":"Bohm K, Sun L, Thakor D, Wirth M (2014) Caveolin-1 limits human influenza A virus (H1N1) propagation in mouse embryo-derived fibroblasts. Virology 462\u2013463:241\u2013253","journal-title":"Virology"},{"issue":"2","key":"2243_CR52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.chom.2014.01.006","volume":"12","author":"R Beale","year":"2014","unstructured":"Beale R, Wise H, Stuart A, Ravenhill BJ, Digard P, Randow F (2014) A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability. Cell Host Microbe 12(2):239\u2013247","journal-title":"Cell Host Microbe"},{"issue":"1","key":"2243_CR53","doi-asserted-by":"publisher","first-page":"e01757","DOI":"10.1128\/JVI.01757-16","volume":"91","author":"P Zhu","year":"2017","unstructured":"Zhu P, Liang L, Shao X, Luo W, Jiang S, Zhao Q et al (2017) Host cellular protein TRAPPC6A\u0394 interacts with influenza A virus M2 protein and regulates viral propagation by modulating M2 trafficking. J Virol 91(1):e01757-e1816","journal-title":"J Virol"},{"issue":"9","key":"2243_CR54","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s11427-010-4048-7","volume":"53","author":"S Mi","year":"2010","unstructured":"Mi S, Li Y, Yan J, Gao GF (2010) Na+\/K+-ATPase \u03b21 subunit interacts with M2 proteins of influenza A and B viruses and affects the virus replication. Sci China Life Sci 53(9):1098\u20131105","journal-title":"Sci China Life Sci"},{"issue":"17","key":"2243_CR55","doi-asserted-by":"publisher","first-page":"8765","DOI":"10.1128\/JVI.00853-10","volume":"84","author":"ML Grantham","year":"2010","unstructured":"Grantham ML, Stewart SM, Lalime EN, Pekosz A (2010) Tyrosines in the Influenza A Virus M2 protein cytoplasmic tail are critical for production of infectious virus particles. J Virol 84(17):8765\u20138776","journal-title":"J Virol"},{"issue":"6","key":"2243_CR56","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1128\/JVI.79.6.3595-3605.2005","volume":"79","author":"MF McCown","year":"2005","unstructured":"McCown MF, Pekosz A (2005) The Influenza A Virus M2cytoplasmic tail is required for infectious virus production and efficient genome packaging. J Virol 79(6):3595\u20133605","journal-title":"J Virol"},{"key":"2243_CR57","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3389\/fimmu.2018.01581","volume":"9","author":"D Dou","year":"2018","unstructured":"Dou D, Revol R, \u00d6stbye H, Wang H, Daniels R (2018) Influenza A virus cell entry, replication virion assembly and movement. Front Immunol 9:1581","journal-title":"Front Immunol"},{"issue":"4","key":"2243_CR58","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1128\/JVI.74.4.1781-1786.2000","volume":"74","author":"M Bui","year":"2000","unstructured":"Bui M, Wills EG, Helenius A, Whittaker GR (2000) Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J Virol 74(4):1781\u20131786","journal-title":"J Virol"},{"issue":"1","key":"2243_CR59","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-biochem-091008-152423","volume":"80","author":"G Grigoryan","year":"2011","unstructured":"Grigoryan G, Moore DT, DeGrado WF (2011) Transmembrane communication: general principles and lessons from the structure and function of the M2 proton channel, K+ channels, and integrin receptors. Annu Rev Biochem 80(1):211\u2013237","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"2243_CR60","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1128\/JVI.06698-11","volume":"86","author":"J Fontana","year":"2012","unstructured":"Fontana J, Cardone G, Heymann JB, Winkler DC, Steven AC (2012) Structural changes in influenza virus at low pH characterized by cryo-electron tomography. J Virol 86(6):2919\u20132929","journal-title":"J Virol"},{"issue":"1","key":"2243_CR61","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.biochem.72.121801.161504","volume":"72","author":"LV Chernomordik","year":"2003","unstructured":"Chernomordik LV, Kozlov MM (2003) Protein-lipid interplay in fusion and fission of biological membranes. Annu Rev Biochem 72(1):175\u2013207","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"2243_CR62","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.virol.2010.12.003","volume":"411","author":"JS Rossman","year":"2011","unstructured":"Rossman JS, Lamb RA (2011) Influenza virus assembly and budding. Virology 411(2):229\u2013236","journal-title":"Virology"},{"issue":"25","key":"2243_CR63","doi-asserted-by":"publisher","first-page":"14610","DOI":"10.1073\/pnas.2235620100","volume":"100","author":"M Takeda","year":"2003","unstructured":"Takeda M, Leser GP, Russell CJ, Lamb RA (2003) Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci U S A 100(25):14610\u201314617","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2243_CR64","doi-asserted-by":"publisher","first-page":"7111","DOI":"10.1128\/JVI.00361-07","volume":"81","author":"BJ Chen","year":"2007","unstructured":"Chen BJ, Leser GP, Morita E, Lamb RA (2007) Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol 81(13):7111\u20137123","journal-title":"J Virol"},{"issue":"17","key":"2243_CR65","doi-asserted-by":"publisher","first-page":"8957","DOI":"10.1128\/JVI.00592-15","volume":"89","author":"P Chlanda","year":"2015","unstructured":"Chlanda P, Schraidt O, Kummer S, Riches J, Oberwinkler H, Prinz S et al (2015) Structural analysis of the roles of Influenza A Virus membrane-associated proteins in assembly and morphology. J Virol 89(17):8957\u20138966","journal-title":"J Virol"},{"issue":"24","key":"2243_CR66","doi-asserted-by":"publisher","first-page":"11538","DOI":"10.1128\/JVI.74.24.11538-11547.2000","volume":"74","author":"P G\u00f3mez-Puertas","year":"2000","unstructured":"G\u00f3mez-Puertas P, Albo C, P\u00e9rez-Pastrana E, Vivo A, Portela A (2000) Influenza virus matrix protein is the major driving force in virus budding. J Virol 74(24):11538\u201311547","journal-title":"J Virol"},{"issue":"1","key":"2243_CR67","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.febslet.2010.11.017","volume":"585","author":"T Shimizu","year":"2011","unstructured":"Shimizu T, Takizawa N, Watanabe K, Nagata K, Kobayashi N (2011) Crucial role of the influenza virus NS2 (NEP) C-terminal domain in M1 binding and nuclear export of vRNP. FEBS Lett 585(1):41\u201346","journal-title":"FEBS Lett"},{"issue":"21","key":"2243_CR68","doi-asserted-by":"publisher","first-page":"13673","DOI":"10.1128\/JVI.79.21.13673-13684.2005","volume":"79","author":"BJ Chen","year":"2005","unstructured":"Chen BJ, Takeda M, Lamb RA (2005) Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly. J Virol 79(21):13673\u201313684","journal-title":"J Virol"},{"issue":"29","key":"2243_CR69","doi-asserted-by":"publisher","first-page":"20067","DOI":"10.1074\/jbc.M114.569178","volume":"289","author":"L Brunotte","year":"2014","unstructured":"Brunotte L, Flies J, Bolte H, Reuther P, Vreede F, Schwemmle M (2014) The nuclear export protein of H5N1 Influenza A viruses recruits matrix 1 (M1) protein to the viral ribonucleoprotein to mediate nuclear export. J Biol Chem 289(29):20067\u201320077","journal-title":"J Biol Chem"},{"issue":"1","key":"2243_CR70","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00249-004-0424-1","volume":"34","author":"C Schroeder","year":"2004","unstructured":"Schroeder C, Heider H, M\u00f6ncke-Buchner E, Lin T-I (2004) The influenza virus ion channel and maturation cofactor M2 is a cholesterol-binding protein. Eur Biophys J 34(1):52\u201366","journal-title":"Eur Biophys J"},{"issue":"7","key":"2243_CR71","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3390\/ijms18071541","volume":"18","author":"L Byrd-Leotis","year":"2017","unstructured":"Byrd-Leotis L, Cummings RD, Steinhauer DA (2017) The interplay between the host receptor and influenza virus hemagglutinin and neuraminidase. Int J Mol Sci 18(7):1541","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2243_CR72","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1743-422X-3-102","volume":"3","author":"J Feng","year":"2006","unstructured":"Feng J, Zhang M, Mozdzanowska K, Zharikova D, Hoff H, Wunner W et al (2006) Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol J 3(1):102","journal-title":"Virol J"},{"issue":"6","key":"2243_CR73","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","volume":"19","author":"F Krammer","year":"2019","unstructured":"Krammer F (2019) The human antibody response to Influenza A virus infection and vaccination. Nat Rev Immunol 19(6):383\u2013397","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2243_CR74","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0928-8244(03)00009-9","volume":"35","author":"W Liu","year":"2003","unstructured":"Liu W, Li H, Chen Y-H (2003) N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication. FEMS Immunol Med Microbiol 35(2):141\u2013146","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"2243_CR75","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","volume":"186","author":"K El Bakkouri","year":"2011","unstructured":"El Bakkouri K, Descamps F, De Filette M, Smet A, Festjens E, Birkett A et al (2011) Universal vaccine based on ectodomain of matrix protein 2 of Influenza A: Fc receptors and alveolar macrophages mediate protection. J Immunol 186(2):1022\u20131031","journal-title":"J Immunol"},{"issue":"9","key":"2243_CR76","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","volume":"172","author":"A Jegerlehner","year":"2004","unstructured":"Jegerlehner A, Schmitz N, Storni T, Bachmann MF (2004) Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol 172(9):5598\u20135605","journal-title":"J Immunol"},{"issue":"5","key":"2243_CR77","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4110\/in.2015.15.5.213","volume":"15","author":"Y-N Lee","year":"2015","unstructured":"Lee Y-N, Kim M-C, Lee Y-T, Kim Y-J, Kang S-M (2015) Mechanisms of cross-protection by influenza virus M2-based vaccines. Immune Netw 15(5):213\u2013221","journal-title":"Immune Netw"},{"key":"2243_CR78","doi-asserted-by":"crossref","unstructured":"Tizard IR (2021) Adjuvants and adjuvanticity. In: Vaccines for Veterinarians. pp. 75\u201386.e71","DOI":"10.1016\/B978-0-323-68299-2.00016-2"},{"key":"2243_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.772550","author":"C Calzas","year":"2021","unstructured":"Calzas C, Mao M, Turpaud M, Viboud Q, Mettier J, Figueroa T et al (2021) Immunogenicity and protective potential of mucosal vaccine formulations based on conserved epitopes of influenza A viruses fused to an innovative ring nanoplatform in mice and chickens. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.772550","journal-title":"Front Immunol"},{"issue":"36","key":"2243_CR80","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1016\/j.vaccine.2021.06.085","volume":"39","author":"RE Haupt","year":"2021","unstructured":"Haupt RE, Harberts EM, Kitz RJ, Strohmeier S, Krammer F, Ernst RK et al (2021) Novel TLR4 adjuvant elicits protection against homologous and heterologous Influenza A infection. Vaccine 39(36):5205\u20135213","journal-title":"Vaccine"},{"key":"2243_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-27965-x","author":"R Haupt","year":"2023","unstructured":"Haupt R, Baracco L, Harberts EM, Loganathan M, Kerstetter LJ, Krammer F et al (2023) Enhancing the protection of influenza virus vaccines with BECC TLR4 adjuvant in aged mice. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-023-27965-x","journal-title":"Sci Rep"},{"key":"2243_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202301801","author":"W Zhu","year":"2023","unstructured":"Zhu W, Park J, Pho T, Wei L, Dong C, Kim J et al (2023) ISCOMs\/MPLA\u2010adjuvanted SDAD protein nanoparticles induce improved mucosal immune responses and cross\u2010protection in mice. Small. https:\/\/doi.org\/10.1002\/smll.202301801","journal-title":"Small"},{"issue":"2","key":"2243_CR83","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41385-020-0334-2","volume":"14","author":"V Bernasconi","year":"2021","unstructured":"Bernasconi V, Norling K, Gribonika I, Ong LC, Burazerovic S, Parveen N et al (2021) A vaccine combination of lipid nanoparticles and a Cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection. Mucosal Immunol 14(2):523\u2013536","journal-title":"Mucosal Immunol"},{"issue":"36","key":"2243_CR84","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.1016\/j.vaccine.2021.07.037","volume":"39","author":"IG Sakala","year":"2021","unstructured":"Sakala IG, Honda-Okubo Y, Li L, Baldwin J, Petrovsky N (2021) A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization. Vaccine 39(36):5162\u20135172","journal-title":"Vaccine"},{"key":"2243_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9070698","author":"CJ Sei","year":"2021","unstructured":"Sei CJ, Rao M, Schuman RF, Daum LT, Matyas GR, Rikhi N et al (2021) Conserved influenza hemagglutinin, neuraminidase and matrix peptides adjuvanted with ALFQ induce broadly neutralizing antibodies. Vaccines. https:\/\/doi.org\/10.3390\/vaccines9070698","journal-title":"Vaccines"},{"issue":"1","key":"2243_CR86","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.vaccine.2021.11.049","volume":"40","author":"M C\u00f4t\u00e9-Cyr","year":"2022","unstructured":"C\u00f4t\u00e9-Cyr M, Gauthier L, Zottig X, Bourgault S, Archambault D (2022) Recombinant Bacillus subtilis flagellin Hag is a potent immunostimulant with reduced proinflammatory properties compared to Salmonella enterica serovar Typhimurium FljB. Vaccine 40(1):11\u201317","journal-title":"Vaccine"},{"key":"2243_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00498-6","author":"J Subbiah","year":"2022","unstructured":"Subbiah J, Oh J, Kim K-H, Shin C-H, Park BR, Bhatnagar N et al (2022) A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine. NPJ Vaccines. https:\/\/doi.org\/10.1038\/s41541-022-00498-6","journal-title":"NPJ Vaccines"},{"issue":"9","key":"2243_CR88","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.3390\/v14091920","volume":"14","author":"KB Gomes","year":"2022","unstructured":"Gomes KB, Menon I, Bagwe P, Bajaj L, Kang S-M, D\u2019Souza MJ (2022) Enhanced immunogenicity of an influenza ectodomain matrix-2 protein virus-like particle (M2e VLP) using polymeric microparticles for vaccine delivery. Viruses 14(9):1920","journal-title":"Viruses"},{"issue":"13","key":"2243_CR89","doi-asserted-by":"publisher","first-page":"10612","DOI":"10.3390\/ijms241310612","volume":"24","author":"K Braz Gomes","year":"2023","unstructured":"Braz Gomes K, Vijayanand S, Bagwe P, Menon I, Kale A, Patil S et al (2023) Vaccine-induced immunity elicited by microneedle delivery of influenza ectodomain matrix protein 2 virus-like particle (M2e VLP)-loaded PLGA nanoparticles. Int J Mol Sci 24(13):10612","journal-title":"Int J Mol Sci"},{"key":"2243_CR90","first-page":"2259","volume":"77","author":"M Taghizadeh","year":"2022","unstructured":"Taghizadeh M, Dabaghian M (2022) Nasal administration of M2e\/CpG-ODN encapsulated in N-trimethyl chitosan (TMC) significantly increases specific immune responses in a mouse model. Arch Razi Inst 77:2259\u20132268","journal-title":"Arch Razi Inst"},{"issue":"19","key":"2243_CR91","doi-asserted-by":"publisher","first-page":"21872","DOI":"10.1021\/acsami.2c01028","volume":"14","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Li Z, Voyer J, Li Y, Chen X (2022) Flagellin\/virus-like particle hybrid platform with high immunogenicity, safety, and versatility for vaccine development. ACS Appl Mater Interfaces 14(19):21872\u201321885","journal-title":"ACS Appl Mater Interfaces"},{"key":"2243_CR92","doi-asserted-by":"publisher","first-page":"836274","DOI":"10.3389\/fimmu.2022.836274","volume":"13","author":"X Zhuang","year":"2022","unstructured":"Zhuang X, Chen L, Yang S, Xia S, Xu Z, Zhang T, Zeng B, Yu T, Yu N, Wang W, Lu H, Tian M, Jin N (2022) R848 adjuvant laden with self-assembled nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 in mice. Front Immunol 13:836274","journal-title":"Front Immunol"},{"key":"2243_CR93","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.molimm.2022.10.006","volume":"152","author":"T Guo","year":"2022","unstructured":"Guo T, Xiao J, Li L, Xu W, Yuan Y, Yin Y et al (2022) rM2e-\u0394Ply protein immunization induces protection against influenza viruses and its co-infection with Streptococcus pneumoniae in mice. Mol Immunol 152:86\u201396","journal-title":"Mol Immunol"},{"issue":"2","key":"2243_CR94","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.vaccine.2023.12.012","volume":"42","author":"T Opriessnig","year":"2024","unstructured":"Opriessnig T, Gauger PC, Filippsen Favaro P, Rawal G, Magstadt DR, Digard P et al (2024) An experimental universal swine influenza a virus (IAV) vaccine candidate based on the M2 ectodomain (M2e) peptide does not provide protection against H1N1 IAV challenge in pigs. Vaccine 42(2):220\u2013228","journal-title":"Vaccine"},{"issue":"5","key":"2243_CR95","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1021\/acsinfecdis.3c00429","volume":"10","author":"LR Wilks","year":"2024","unstructured":"Wilks LR, Joshi G, Rychener N, Gill HS (2024) Generation of broad protection against influenza with di-tyrosine-cross-linked M2e nanoclusters. ACS Infect Dis 10(5):1552\u20131560","journal-title":"ACS Infect Dis"},{"key":"2243_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.psj.2024.104616","author":"F Jia","year":"2025","unstructured":"Jia F, Wang W, Tian Y, Zahra A, He Y, Ge C et al (2025) Delivery of dendritic cells targeting 3M2e-HA2 nanoparticles with a CpG adjuvant via lysosomal escape of Salmonella enhances protection against H9N2 avian influenza virus. Poult Sci. https:\/\/doi.org\/10.1016\/j.psj.2024.104616","journal-title":"Poult Sci"},{"issue":"2","key":"2243_CR97","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.virol.2012.09.014","volume":"435","author":"EA Blokhina","year":"2013","unstructured":"Blokhina EA, Kuprianov VV, Stepanova LA, Tsybalova LM, Kiselev OI, Ravin NV et al (2013) A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles. Virology 435(2):293\u2013300","journal-title":"Virology"},{"key":"2243_CR98","first-page":"1","volume":"2013","author":"L Wang","year":"2013","unstructured":"Wang L, Wang Y-C, Feng H, Ahmed T, Compans RW, Wang B-Z (2013) Virus-like particles containing the tetrameric ectodomain of influenza matrix protein 2 and flagellin induce heterosubtypic protection in mice. BioMed Res Int 2013:1\u201312","journal-title":"BioMed Res Int"},{"issue":"33","key":"2243_CR99","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1016\/j.vaccine.2010.02.103","volume":"28","author":"A Jegerlehner","year":"2010","unstructured":"Jegerlehner A, Wiesel M, Dietmeier K, Zabel F, Gatto D, Saudan P et al (2010) Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies. Vaccine 28(33):5503\u20135512","journal-title":"Vaccine"},{"key":"2243_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/v15020392","author":"K-B Chu","year":"2023","unstructured":"Chu K-B, Quan F-S (2023) Respiratory viruses and virus-like particle vaccine development: how far have we advanced? Viruses. https:\/\/doi.org\/10.3390\/v15020392","journal-title":"Viruses"},{"key":"2243_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/v15051109","author":"M Kheirvari","year":"2023","unstructured":"Kheirvari M, Liu H, Tumban E (2023) Virus-like particle vaccines and platforms for vaccine development. Viruses. https:\/\/doi.org\/10.3390\/v15051109","journal-title":"Viruses"},{"issue":"1","key":"2243_CR102","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1134\/S000629791201004X","volume":"77","author":"NV Ravin","year":"2012","unstructured":"Ravin NV, Kotlyarov RY, Mardanova ES, Kuprianov VV, Migunov AI, Stepanova LA et al (2012) Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein. Biochem Mosc 77(1):33\u201340","journal-title":"Biochem Mosc"},{"issue":"29","key":"2243_CR103","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1016\/j.vaccine.2015.04.066","volume":"33","author":"NV Ravin","year":"2015","unstructured":"Ravin NV, Blokhina EA, Kuprianov VV, Stepanova LA, Shaldjan AA, Kovaleva AA et al (2015) Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: insertion of multiple copies of M2e increases immunogenicity and protective efficiency. Vaccine 33(29):3392\u20133397","journal-title":"Vaccine"},{"issue":"38","key":"2243_CR104","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1016\/j.vaccine.2020.07.015","volume":"38","author":"J Wei","year":"2020","unstructured":"Wei J, Li Z, Yang Y, Ma X, An W, Ma G et al (2020) A biomimetic VLP influenza vaccine with interior NP\/exterior M2e antigens constructed through a temperature shift-based encapsulation strategy. Vaccine 38(38):5987\u20135996","journal-title":"Vaccine"},{"key":"2243_CR105","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2256422","author":"F Xiong","year":"2023","unstructured":"Xiong F, Zhang C, Shang B, Zheng M, Wang Q, Ding Y et al (2023) An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses. Emerg Microbes Infect. https:\/\/doi.org\/10.1080\/22221751.2023.2256422","journal-title":"Emerg Microbes Infect"},{"issue":"7","key":"2243_CR106","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/acs.biomac.4c00365","volume":"25","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhuang X, Hu Y, Chen J, Hao K, Tang Z et al (2024) Constructing a ready-to-use mRNA vaccine delivery system for the prevention of influenza A virus, utilizing FDA-approved raw materials. Biomacromol 25(7):4281\u20134291","journal-title":"Biomacromol"},{"key":"2243_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00594","author":"C Zhang","year":"2019","unstructured":"Zhang C, Maruggi G, Shan H, Li J (2019) Advances in mRNA vaccines for infectious diseases. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.00594","journal-title":"Front Immunol"},{"issue":"32","key":"2243_CR108","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","volume":"29","author":"CB Turley","year":"2011","unstructured":"Turley CB, Rupp RE, Johnson C, Taylor DN, Wolfson J, Tussey L et al (2011) Safety and immunogenicity of a recombinant M2e\u2013flagellin influenza vaccine (STF2.4xM2e) in healthy adults. Vaccine 29(32):5145\u20135152","journal-title":"Vaccine"},{"key":"2243_CR109","unstructured":"Corporation V. Comparative safety and immunogenicity of 1.0 \u00b5g intramuscular (i.m.) and 2.0 \u00b5g subcutaneous (s.c.) dosing with VAX102 (M2e-flagellin) universal influenza vaccine in healthy adults, 2011."},{"issue":"1","key":"2243_CR110","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11033-024-10146-y","volume":"52","author":"H Afzal","year":"2025","unstructured":"Afzal H, Murtaza A, Cheng L-T (2025) Structural engineering of flagellin as vaccine adjuvant: quest for the minimal domain of flagellin for TLR5 activation. Mol Biol Rep 52(1):104","journal-title":"Mol Biol Rep"},{"key":"2243_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110295","author":"ES Mardanova","year":"2025","unstructured":"Mardanova ES, Ravin NV (2025) Flagellin as a versatile adjuvant platform: genetic fusion approaches for next-generation vaccines. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms262110295","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2243_CR112","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1039\/B611613M","volume":"3","author":"LH Pinto","year":"2007","unstructured":"Pinto LH, Lamb RA (2007) Controlling influenza virus replication by inhibiting its proton channel. Mol BioSyst 3(1):18\u201323","journal-title":"Mol BioSyst"},{"key":"2243_CR113","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.antiviral.2017.01.006","volume":"140","author":"Y Hu","year":"2017","unstructured":"Hu Y, Musharrafieh R, Ma C, Zhang J, Smee DF, DeGrado WF et al (2017) An M2\u2013V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses. Antiviral Res 140:45\u201354","journal-title":"Antiviral Res"},{"issue":"7","key":"2243_CR114","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10096-020-03840-9","volume":"39","author":"T Lampejo","year":"2020","unstructured":"Lampejo T (2020) Influenza and antiviral resistance: an overview. Eur J Clin Microbiol Infect Dis 39(7):1201\u20131208","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9507","key":"2243_CR115","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(06)67970-1","volume":"367","author":"T Jefferson","year":"2006","unstructured":"Jefferson T, Demicheli V, Rivetti D, Jones M, Di Pietrantonj C, Rivetti A (2006) Antivirals for influenza in healthy adults: systematic review. Lancet 367(9507):303\u2013313","journal-title":"Lancet"},{"key":"2243_CR116","doi-asserted-by":"publisher","first-page":"104780","DOI":"10.1016\/j.antiviral.2020.104780","volume":"178","author":"PH Jalily","year":"2020","unstructured":"Jalily PH, Duncan MC, Fedida D, Wang J, Tietjen I (2020) Put a cork in it: plugging the M2 viral ion channel to sink influenza. Antiviral Res 178:104780","journal-title":"Antiviral Res"},{"issue":"4","key":"2243_CR117","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.1216526110","volume":"110","author":"J Wang","year":"2013","unstructured":"Wang J, Wu Y, Ma C, Fiorin G, Wang J, Pinto LH et al (2013) Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. Proc Natl Acad Sci U S A 110(4):1315\u20131320","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2243_CR118","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.1021\/jm5005804","volume":"57","author":"M Rey-Carrizo","year":"2014","unstructured":"Rey-Carrizo M, Barniol-Xicota M, Ma C, Frigol\u00e9-Vivas M, Torres E, Naesens L et al (2014) Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus. J Med Chem 57(13):5738\u20135747","journal-title":"J Med Chem"},{"issue":"10","key":"2243_CR119","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1128\/AAC.00476-09","volume":"53","author":"JT Nguyen","year":"2009","unstructured":"Nguyen JT, Hoopes JD, Smee DF, Prichard MN, Driebe EM, Engelthaler DM et al (2009) Triple combination of Oseltamivir, Amantadine, and Ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agents Chemother 53(10):4115\u20134126","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2243_CR120","doi-asserted-by":"publisher","first-page":"e9332","DOI":"10.1371\/journal.pone.0009332","volume":"5","author":"JT Nguyen","year":"2010","unstructured":"Nguyen JT, Hoopes JD, Le MH, Smee DF, Patick AK, Faix DJ, Blair PJ, de Jong MD, Prichard MN, Went GT (2010) Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro. PLoS ONE 5(2):e9332","journal-title":"PLoS ONE"},{"key":"2243_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.859033","author":"NM Ashtiwi","year":"2022","unstructured":"Ashtiwi NM, Sarr D, Nagy T, Reneer ZB, Tripp RA, Rada B (2022) The Hypothiocyanite and Amantadine combination treatment prevents lethal Influenza A virus infection in mice. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.859033","journal-title":"Front Immunol"},{"key":"2243_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/ma16155363","author":"DA Serov","year":"2023","unstructured":"Serov DA, Khabatova VV, Vodeneev V, Li R, Gudkov SV (2023) A review of the antibacterial, fungicidal and antiviral properties of selenium nanoparticles. Materials. https:\/\/doi.org\/10.3390\/ma16155363","journal-title":"Materials"},{"key":"2243_CR123","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2147\/IJN.S155994","volume":"13","author":"Y Li","year":"2018","unstructured":"Li Y, Lin Z, Guo M, Zhao M, Xia Y, Wang C et al (2018) Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with Amantadine through ROS-mediated AKT signaling pathways. Int J Nanomedicine 13:2005\u20132016","journal-title":"Int J Nanomedicine"},{"key":"2243_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.poly.2020.114590","author":"CN Banti","year":"2020","unstructured":"Banti CN, Kourkoumelis N, Hatzidimitriou AG, Antoniadou I, Dimou A, Rallis M et al (2020) Amantadine copper(II) chloride conjugate with possible implementation in influenza virus inhibition. Polyhedron. https:\/\/doi.org\/10.1016\/j.poly.2020.114590","journal-title":"Polyhedron"},{"issue":"1","key":"2243_CR125","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/22221751.2018.1558962","volume":"8","author":"Y Yao","year":"2019","unstructured":"Yao Y, Wang H, Chen J, Shao Z, He B, Chen J et al (2019) Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine. Emerg Microbes Infect 8(1):45\u201354","journal-title":"Emerg Microbes Infect"},{"key":"2243_CR126","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00745-21","author":"S Van den Hoecke","year":"2021","unstructured":"Van den Hoecke S, Ballegeer M, Vrancken B, Deng L, Job ER, Roose K et al (2021) In vivo therapy with M2e-specific IgG selects for an Influenza A virus mutant with delayed Matrix Protein 2 expression. MBio. https:\/\/doi.org\/10.1128\/mBio.00745-21","journal-title":"MBio"},{"key":"2243_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28721","author":"TYW Sun","year":"2023","unstructured":"Sun TYW, Zou P, Wang Q, Liu J, Liu W, Huang J, Wu F (2023) M2e-specific antibodies protect against influenza PR8 virus in an isotype and route dependent manner. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.28721","journal-title":"J Med Virol"},{"issue":"3","key":"2243_CR128","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.chom.2015.01.005","volume":"17","author":"M Weber","year":"2015","unstructured":"Weber M, Sediri H, Felgenhauer U, Binzen I, B\u00e4nfer S, Jacob R et al (2015) Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. Cell Host Microbe 17(3):309\u2013319","journal-title":"Cell Host Microbe"},{"issue":"7","key":"2243_CR129","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1128\/JVI.03610-14","volume":"89","author":"S-F Hsu","year":"2015","unstructured":"Hsu S-F, Su W-C, Jeng K-S, Lai MMC, Sandri-Goldin RM (2015) A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication. J Virol 89(7):3671\u20133682","journal-title":"J Virol"},{"issue":"19","key":"2243_CR130","doi-asserted-by":"publisher","first-page":"8389","DOI":"10.1128\/JVI.00041-16","volume":"90","author":"M Weber-Gerlach","year":"2016","unstructured":"Weber-Gerlach M, Weber F, Gack M (2016) To conquer the host, influenza virus is packing it in: interferon-antagonistic strategies beyond NS1. J Virol 90(19):8389\u20138394","journal-title":"J Virol"},{"issue":"1","key":"2243_CR131","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1038\/s41467-019-12632-5","volume":"10","author":"M Moriyama","year":"2019","unstructured":"Moriyama M, Koshiba T, Ichinohe T (2019) Influenza A virus M2 protein triggers mitochondrial DNA-mediated antiviral immune responses. Nat Commun 10(1):4624","journal-title":"Nat Commun"},{"issue":"2","key":"2243_CR132","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1006\/viro.1998.9508","volume":"252","author":"AAEb Garc\u00eda-Sastre","year":"1998","unstructured":"Garc\u00eda-Sastre AAEb, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T (1998) Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252(2):324\u2013330","journal-title":"Virology"},{"issue":"7","key":"2243_CR133","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1080\/15548627.2019.1580089","volume":"15","author":"R Wang","year":"2019","unstructured":"Wang R, Zhu Y, Lin X, Ren C, Zhao J, Wang F et al (2019) Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production. Autophagy 15(7):1163\u20131181","journal-title":"Autophagy"},{"issue":"4","key":"2243_CR134","doi-asserted-by":"publisher","first-page":"e01984","DOI":"10.1128\/JVI.01984-18","volume":"93","author":"RYZ Wang","year":"2019","unstructured":"Wang RYZ, Zhao J, Ren C, Li P, Chen H, Jin M, Zhou H (2019) Autophagy promotes replication of Influenza A virus in vitro. J Virol 93(4):e01984-e11918","journal-title":"J Virol"},{"key":"2243_CR135","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s10495-007-0071-y","volume":"12","author":"OP Zhirnov","year":"2007","unstructured":"Zhirnov OP, Klenk HD (2007) Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Apoptosis 12:1419\u20131432","journal-title":"Apoptosis"},{"issue":"10","key":"2243_CR136","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s13238-010-0115-x","volume":"1","author":"Z Guan","year":"2010","unstructured":"Guan Z, Liu D, Mi S, Zhang J, Ye Q, Wang M et al (2010) Interaction of Hsp40 with influenza virus M2 protein: implications for PKR signaling pathway. Protein Cell 1(10):944\u2013955","journal-title":"Protein Cell"}],"container-title":["Virus Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-026-02243-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11262-026-02243-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-026-02243-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:43:07Z","timestamp":1790394187000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11262-026-02243-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":136,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2243"],"URL":"https:\/\/doi.org\/10.1007\/s11262-026-02243-w","relation":{},"ISSN":["0920-8569","1572-994X"],"issn-type":[{"value":"0920-8569","type":"print"},{"value":"1572-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}